Yangmin Hu
Biographic Data
| ID | 9995531 |
|---|---|
| NAME | Yangmin Hu |
| GIVEN NAMES | Yangmin |
| FAMILY NAME | Hu |
| SIGNATURE | HU Y |
| AFFILIATIONS | Second Affiliated Hospital of Zhejiang University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections
Background: Overuse of antibiotics among patients with upper respiratory tract infections (URTIs) is a worldwide problem. In China, approximately 70% of outpatients with URTIs are treated with antibiotics, often via intravenous infusion. This study aimed to evaluate whether a pharmacist-led multidimensional intervention reduces the use of intravenous (IV) antibacterial drug infusion among patients with bacterial URTIs. Methods and analysis: This …
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective pr…
No prominent works on this page.
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individualized treatment. On the basis of summarizing the existing clinical studies, and based on the practical experience of each expert in their respective pr…
Impact of pharmaceutical intervention on the use of intravenous antibiotics in patients with bacterial upper respiratory tract infections
Background: Overuse of antibiotics among patients with upper respiratory tract infections (URTIs) is a worldwide problem. In China, approximately 70% of outpatients with URTIs are treated with antibiotics, often via intravenous infusion. This study aimed to evaluate whether a pharmacist-led multidimensional intervention reduces the use of intravenous (IV) antibacterial drug infusion among patients with bacterial URTIs. Methods and analysis: This …
Clinical trial (2 works) · Adverse effect (1 work) · Antibiotic Use and Resistance (1 work) · Antibiotics (1 work) · Antibiotics Pharmacokinetics and Efficacy (1 work) · Antimicrobial Resistance in Staphylococcus (1 work) · Bacterial Identification and Susceptibility Testing (1 work) · Compassionate Use (1 work) · Drug (1 work) · Emergency department (1 work)